Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival?
Explore this paper's citation graph
Summary
Preliminary data suggest that radiomics is capable of discriminating MSI from microsatellite stable mCRC and may play a role as an imaging biomarker in the future.
- Type
- review
- Published
- 2020-04-01
- Cited by
- 27
- References
- 103
- Access
- Open access
- OpenAlex
- https://openalex.org/W3014869101
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:215606648
Keywords
Colorectal cancer, Key (lock), Medicine, Immunotherapy, Cancer
References
- Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing.
- CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes
- Next-Generation Sequencing.
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.
- The Consensus Molecular Subtypes of Colorectal Cancer
- Current and future molecular diagnostics in colorectal cancer and colorectal adenoma.
- Neoantigens in cancer immunotherapy
- Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.
- Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer
- Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
- IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics.
- The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository
- Molecular Origins of Cancer
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
- MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
- Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis
- A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.
- What is next generation sequencing?
- Tumor‐infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
Cited by
- Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications
- Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer
- In situ amplified QCM immunoassay for carcinoembryonic antigen with colorectal cancer using horseradish peroxidase nanospheres and enzymatic biocatalytic precipitation.
- Current advancements and future perspectives of immunotherapy in colorectal cancer research.
- A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.
- Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
- The Mechanisms Leading to Distinct Responses to PD-1/PD-L1 Blockades in Colorectal Cancers With Different MSI Statuses
- Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
- Potential of olive oil and its phenolic compounds as therapeutic intervention against colorectal cancer: a comprehensive review
- Indian consensus statement on the management of metastatic colorectal cancer
- Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer
- Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study
- Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives.
- Oncolytic adenovirus H101 ameliorate the efficacy of anti‐PD‐1 monotherapy in colorectal cancer
- The Role of Tumor Microenvironment and Immune Response in Colorectal Cancer Development and Prognosis
- Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer
- Role of AI and digital pathology for colorectal immuno-oncology
- Evaluation of Microsatellite Instability Molecular Analysis versus Immuno-Histochemical Interpretation in Malignant Neoplasms with Different Localizations
- Preoperative Prediction of Microsatellite Instability in Rectal Cancer Using Five Machine Learning Algorithms Based on Multiparametric MRI Radiomics
- Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
Related papers
- Expression of PTTG and its significance in colorectal cancer
- δ-catenin Expression Correlates with Cell Proliferation in Colorectal Cancer
- PC analysis of key words — And key key words
- Expression of Galecitn-9 in colorectal cancer and its clinical significance
- Data from Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal Colon
- SLC25A24, a potential and novel biomarker for diagnosing colorectal cancer
- Correlation between the expression of the BAG-1 gene and clinicopathologic factors in colorectal cancer